References
- Shapiro S, Venet W, Strax P. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 62: 349
- Tabár L, Fagerberg G, Gad A. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1: 829–32
- Andersson I, Aspegren K, Janzon L. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297: 943–8
- Frisell J, Eklund G, Hellström L. Randomized study of mammographic screening—preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49–56
- Nyström L, Rutqvist L E, Wall S. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973–8
- Socialstyrelsen. Allmänna råd från Socialstyrelsen: Mammografiscreening. 1986; 3, General guidelines from the National Board of Health and Welfare: Mammography screening in Swedish
- Frisell J, Glas U, Hellström L. Randomized mammographic screening for breast cancer in Stockholm. Design, first rounds results, and comparisons. Breast Cancer Res Treat 1986; 8: 45–54
- Tabar L, Fagerberg G, Duffy S W. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiologic clinics of North America 1992; 30: 187–210
- Azavedo E, Svane G. Radial scars detected mammographi-cally in a breast cancer screening programme. Eur J Radiol 1992; 15: 18–21
- Kirkpatrick A, Törn berg S, Thijssen M AO. European guidelines for quality assurance in mammography screening. Commission of the European Community, Luxembourg 1993
- Frisell J, Eklund G, Nilsson R. Additional value of fine-needle aspiration biopsy in a mammographic screening trial. Br J Surg 1989; 76: 840–3
- Day N E, Williams D RR, Khaw K T. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954–8